Stock was way oversold, and had 4 new buy ratings last week with an avg target of $16-$17. That plus what the company put out about it's progress with the trials, I think gave this baby a little spark.
I feel just a sign of BIG things to come. Good luck to all.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.